Home

“The next phase of iPSC-derived cell therapies will transform lives across an extraordinary spectrum of disease, including those with Parkinson’s disease, diabetes, immunological disorders, heart disease, and cancer, but only through collaboration. The JSRM and ISCT partnership recognizes that each of these are possible only through the integration of work at every level, from the discoveries of individual scientists through proven products and therapies delivered by highly trained physicians and caregivers across many nations and health systems. Understanding this process and weaving together the many threads into the ropes and cables that bring the many forward is one of the most exciting and rewarding challenges of our time. Join us!”

“The future of iPSC-derived cell therapies is being defined today. Patients and clinicians in every town and country demand high quality, safe and effective therapies that are also accessible and affordable. The ISCT–JSRM Joint Symposium provides that forum where the leading edge of the iPSC community come together … scientists, developers, clinicians, regulators, manufacturers, educators, patient advocates, payors, and health systems. We share progress, define challenges and accelerate our shared mission of safe, effective and accessible cell-based therapies world-wide.”